Advertisement
Advertisement
LCTX
Lineage Cell Therapeutics, Inc.
1.04
USDSponsored
-0.04
-3.70%
Nov 10, 15:22 UTC -5
Closed
After-Market
1.04
0.00
+0.10%
Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc. Financial Snapshot
| Market Cap | 263.28M |
| Beta | 1.68 |
| Earnings Per Share (EPS) | -0.19 |
| Price-to-Book (P/B) Ratio | 4.29 |
| Operating Margin | -246.58% |
| Total Debt/Equity (D/E) | 0.08% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -73.06% |
| Current Ratio | 6.61% |
| Free Cash Flow | -15.48M |
